Focus on sticking to the peak forever -- the enlightenment of Jianfeng Group's 60 years of entrepreneurship
Release time:
2020-07-31
Editor's Note: 11# March 20 , Jinhua Daily 1 edition published "Focus on Climbing the Peak Eternal-Enlightenment of Jianfeng Group's Entrepreneurship 60 " written by the reporter of the newspaper, which is specially reprinted by this newspaper.
Focus on Climbing to the Peak for All Times
-Enlightenment of Jianfeng Group's Entrepreneurship 60
Jinhua Daily Reporter Shao Xuilian
As of the end of the third quarter of this year, total assets 47.88 .5 billion yuan, net assets 33.66 .7 billion yuan, and net profit attributable to the parent company reached 4.88 .9 billion yuan, earnings per share 1.42 yuan. Recently, Jianfeng Group disclosed its beautiful third quarter report of 2018 , celebrating the 35th anniversary of its venture 60 with its best operating results in history.
60 years. With sustained and steady high-quality development, the peak people are moving towards a comprehensive modern enterprise group with strong core competitiveness.
, the first generation of peak people built the first cement factory in Jinhua history at the foot of peak mountain. 1983# Beginning in , through horizontal alliances with township enterprises, the formation of enterprise groups, and the implementation of shareholding reforms, Peak developed from a small state-owned cement plant to the first listed company in China's cement industry. Since then, in the stage of diversification, the peak will develop the pharmaceutical industry into the second pillar industry. 2007 , with the central enterprise China Building Materials, to participate in the formation of Southern Cement, the cement industry focus of strategic transfer; at the same time, through mergers and acquisitions, scientific and technological innovation, the pharmaceutical industry to further develop.
33 participating and holding subsidiaries, involving six major industries of building materials, medicine, health, modern logistics, international trade and communication cables. It is the earliest existing A listed company in our province. On the 63rd anniversary of
25#, Chairman Jiang Xiaomeng said that Jianfeng Group's continued stability benefits from its long-term strategic positioning of focusing on industry, which is the value orientation of Jianfeng and the responsibility of the enterprise. At the same time, it benefits from the combination of cyclical and non-cyclical dual-main business operating structure, and benefits from the core competitiveness formed in the long-term market competition. Cement is the foundation of the enterprise. Peak timely transfers the strategic focus of the cement industry to the areas along the national "the belt and road initiative", strengthens intelligent management and green production, and ensures excellent quality and profitability. As one of the "Top 50 Cement in China" and one of the
large enterprises with the state's key support for the structural adjustment of the cement industry, Spike Cement has established its position as a cost leader in the regional market, especially by virtue of its profitability per ton of cement, which ranks among the top in the industry. In the pharmaceutical sector, Jianfeng Group, on the one hand, has increased industrial mergers and acquisitions and improved the industrial chain. At present, Jianfeng Pharmaceutical has owned
wholly-owned, holding and participating pharmaceutical research and development and production enterprises. There are 3 pharmaceutical trading enterprises, which have established the production system of three major production bases of pharmaceutical intermediate raw materials, proprietary Chinese medicine preparations and chemical medicine preparations. On the other hand, intensify the development of new products, and form a research and development system with 1 provincial drug research institutes, 3 academician expert workstations, 4 postdoctoral workstations as the leading research and development institutions and four innovative drug development subjects. At present, it has 52 international and domestic patents, including 43 invention patents, ranking the top three in the market share of leading products, and increasing the research and development of anti-tumor drugs and infant drugs to become a technology leader in subdivided fields. Pattern: Open and Inclusive
The strategic transfer of cement industry is cooperation and integration. The sudden rise of the pharmaceutical industry is also inseparable from cooperation and integration. For the "old enterprise" of Jianfeng Group, the partners feel the same: the pattern is very large. In 2007
Kang Litao, general manager of Shanghai North Carolina Pharmaceutical, said that after joining Jianfeng Group, he deeply felt that although this is an old listed company restructured by a state-owned enterprise, the degree of standardization, marketization, and modernization is very high. The position of the helmsman is high, especially the high-tech talents are highly respected.
# Wang Yiyan, deputy manager of 104 daye peak manufacturing department, is a local and entered the enterprise in 2007
years in a row. Although some people often want to pay them a high salary, they all say with one voice: "I just want to be a peak worker." , as a high-tech peak pharmaceutical sector, has gathered a group of high-tech talents. The peak meets the needs of talents to "build a nest and attract the phoenix". Where the talents are, the R & D institutions will be established. It has attracted a large number of industry leaders and "returnees" talents, and promoted the innovation and development of new products and drugs.
Some people say that corporate culture is the boss culture. Jiang Xiaomeng started as a worker in Jianfeng Group, but he is also a recognized expert entrepreneur; as the chairman of a listed company, he is observing the general trend and seeking great things, but he has no airs in front of the employees, long-distance business trips, and the driver is tired on the way., He will drive by himself and let the driver take a rest in the passenger seat. He once said that the invisible road lies in seizing the opportunity. The impermanent law lies in taking advantage of the situation. Great skill selflessness lies in uniting people's hearts.
60 is a group of peak people with similar values and a unique peak culture leading the growth of the workforce. Over the years, Jianfeng Group has continuously integrated resources and added more and more new employees. Next, in the face of the complicated economic situation and fully competitive industry pattern, the adjustment of industrial structure will be increased, the integration and improvement of M & A enterprises need to be accelerated, and the training and upgrading of talents will be accelerated. It is necessary to require the peak to be in addition to the values of "being brave to open up, keeping pace with the times, and climbing the peak forever, integrate into the corporate culture of" innovation, tolerance, honesty and responsibility.
Management: Standardization and Science
If "Cooperation and Innovation to Strengthen the Main Business" emphasizes openness and inclusiveness, "Standardization and Science for Development" emphasizes management.
OA management system, financial management system, human resource management system, video conference system, etc. covering all enterprises of the group company, it realizes convenient management of cross-regional development while improving daily work efficiency. In addition, we will continue to carry out fine management. Through
on-site management of lean production, benchmarking management and comprehensive budget management, we will institutionalize and proceduralize them and become the daily management procedures and work habits of employees. Establish an assessment and evaluation system for managers at all levels, use the evaluation system to stimulate the motivation of managers, restrict the behavior of managers, and continue to promote the development of enterprise management to a high level and high efficiency. In order to promote the optimization of enterprise organization and post optimization, Jianfeng Group introduced the "amoeba" management concept in 2016
However, Jiang Xiaomeng said that as an enterprise manager, one must have a clear mind. Today's success does not mean eternal success in the future. Past glory does not mean eternal glory in the future. The management of a successful enterprise is always on the road. "We still have a lot to improve, improve and reform. For example, we still have a gap with advanced companies in terms of the quality and speed of innovative research and development, and we still have a lot to do in terms of lean production, technological innovation, cost control and seeking connotative growth." He said, "In the future, while doing a good business, we will pay more attention to social responsibility. Our goal is to be a century-old enterprise, a respected enterprise, so we will never be satisfied."
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page